Title:
TERMINAL DEVICE AND METHOD
Document Type and Number:
WIPO Patent Application WO/2021/066135
Kind Code:
A1
Abstract:
A receiving unit that receives an SIB1 and a higher-layer processing unit that applies a channel bandwidth on the basis of receiving the SIB1 are provided. If nr-Unlicensed is present in servingCellConfigCommon, the higher-layer processing unit considers NR-U to have been set for a serving cell, and, if a channel bandwidth associated with a maximum transmission bandwidth setting that is the same as, or wider than, the bandwidth of an initial BWP of the NR-U and the same as, or narrower than, carrierBandwidth, is supported, the higher-layer processing unit applies a supported NR-U channel bandwidth in association with a maximum transmission bandwidth that is the same as, or wider than, the initial BWP bandwidth of the NR-U and is encompassed by carrierBandwidth.
Inventors:
OUCHI WATARU
NOGAMI TOSHIZO
LEE TAEWOO
SUZUKI SHOICHI
YOSHIMURA TOMOKI
LIN HUIFA
NAKASHIMA DAIICHIRO
NOGAMI TOSHIZO
LEE TAEWOO
SUZUKI SHOICHI
YOSHIMURA TOMOKI
LIN HUIFA
NAKASHIMA DAIICHIRO
Application Number:
PCT/JP2020/037519
Publication Date:
April 08, 2021
Filing Date:
October 02, 2020
Export Citation:
Assignee:
SHARP KK (JP)
International Classes:
H04W16/14; H04W48/18; H04W72/04
Foreign References:
| JP2019161527A | 2019-09-19 |
Other References:
INTEL CORPORATION: "Wideband operation for NR-unlicensed", 3GPP TSG RAN WG1 #98 RL-1908628, 30 August 2019 (2019-08-30), XP051765236
MEDIATEK INC .: "Wideband operation for NR-U.", 3GPP TSG RAN WG1 #97 RL-1906547, 17 May 2019 (2019-05-17), XP051727998
ZTE CORPORATION: "Clarification on BS and UE channel bandwidth", 3GPP TSG RAN WG4 #90BIS R4- 1903280, 12 April 2019 (2019-04-12), XP051713710
MEDIATEK INC .: "Wideband operation for NR-U.", 3GPP TSG RAN WG1 #97 RL-1906547, 17 May 2019 (2019-05-17), XP051727998
ZTE CORPORATION: "Clarification on BS and UE channel bandwidth", 3GPP TSG RAN WG4 #90BIS R4- 1903280, 12 April 2019 (2019-04-12), XP051713710
Attorney, Agent or Firm:
NISHIZAWA Kazuyoshi et al. (JP)
Download PDF:
Previous Patent: MONOCLONAL ANTIBODY OR ANTIBODY FRAGMENT AGAINST CANINE CD20
Next Patent: THERAPEUTIC AGENT FOR MUSCULAR DYSTROPHY
Next Patent: THERAPEUTIC AGENT FOR MUSCULAR DYSTROPHY